600421 Hubei Huarong Holding
- 6.43
- -0.28-4.17%
About Hubei Huarong Holding Company
The company, formerly known as Wuhan Spring Bioengineering Co., Ltd., was approved by the Hubei Economic System Reform Commission in November 1997 (No. 343), and was jointly initiated by Wuhan Biyaxin Bioengineering Co., Ltd. (now renamed “Wuhan Next-Generation Technology Co., Ltd.”), Wuhan Donghu New Technology Development Zone Development Corporation, Wuhan Cigarette Partner Bioengineering Co., Ltd. (now renamed “Shanghai Rixingkang Biotechnology Co., Ltd.”), Hubei University of Traditional Chinese Medicine, Tongji Medical University and Fudan University (Hubei) Life Science Experimental Base. The company's main business is the processing and manufacture of PC (PrecastConcrete concrete precast) molds, molds, and truss bars. The company's main products are prefabricated component (PC) molds, mold tables, tooling shelves and truss bars.
Company Profile
Company Executives
- Name
- Position
- Salary
- lianghui zhou
- Chairman，directors，general manager，Strategy Committee Members，Remuneration and Assessment Committee Members，Nomination Committee Members
- 1.05M
- chaoyang jin
- Vice Chairman，directors，Strategy Committee Members
- 50.00K
- qu shuai
- directors，Board Secretary，Executive Deputy General Manager，Strategy Committee Members，Audit Committee Members
- 716.30K
- dandan han
- directors，Strategy Committee Members
- 50.00K
- jinyong wang
- Independent directors，Strategy Committee Members，Audit Committee Members，Nomination Committee Members
- 100.00K
- yu cai
- Independent directors，Audit Committee Member，Member of the Remuneration and Assessment Committee，Nomination Committee Members
- --
- lei che
- Independent directors，Remuneration and Assessment Committee Members，Audit Committee Members
- 100.00K
- xiujuan chen
- Securities affairs representative，Employee supervisors
- 173.64K
- kanming huang
- Supervisory Board Convener，auditors
- 30.00K
- andi jiang
- auditors
- 30.00K
- caibing wen
- Deputy General Manager
- 606.14K
- feng jin
- Chief Financial Officer
- 371.64K
Analysis
Price Target
No Data
